Articles, App Notes, Case Studies, & White Papers

1. Communication And Transparency In Secondary Supply Qualification 8/12/2024

   What should you look for when searching for the right vendor to help you maintain security of raw materials and how can you establish communication that builds confidence?

2. Regulatory Expertise And CMC Document Preparation To Support mRNA-Based Therapeutic Development 10/7/2024

   Explore the regulatory requirements for mRNA drug substances and products, the importance of phase-appropriate quality, and insights on creating CMC documentation to ensure compliance.

3. Potent Immune Response With Vernal's LNP-mRNAs 4/26/2024

   As mRNA medicine continues to evolve, understand how trusted manufacturing partners will continue to play a pivotal role in translating innovative concepts into clinical reality.

4. Study Viral Infection In Resting Human CD4+ T Cells 11/28/2023

   Explore a study proving how synthetic single guide RNAs were used to optimize the editing conditions for resting human CD4+ T cells and maintain high cell viability for several weeks post Nucleofection.

5. Improving U.S. Drug Supply Stability Through Continuous Nanoparticle Processing 8/5/2025

   Learn about a continuous manufacturing platform designed to help overcome challenges in domestic pharmaceutical production, including scale-up barriers and production variability.

6. Your Strategy To Manufacture, No Longer A One-Size-Fits-All 5/14/2019

   The traditional method of big batch manufacturing must change as companies move away from the one-size-fits-all blockbuster model toward more innovative, targeted biologics that deliver better outcomes.

7. How Pattern Search Finds Anomaly Patterns In Historical Machine Data 10/21/2020

   Owing to the sheer volume of data streaming from sensor profiles, anomalies observed during process monitoring in historical data are extremely difficult to search due to a lack of time series search tools. 

8. What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan? 5/9/2023

   Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.

9. Biopharma's Battle With Scope 3 Emissions 9/3/2024

   Given the numerous stakeholders involved throughout a product's lifecycle and the limited direct control companies have, how can biopharma organizations effectively measure and manage Scope 3 emissions?

10. Ready To Amplify Plasmid (pDNA) In Bacteria? 11/14/2023

    Explore how to use and amplify pDNA from the development of recombinant proteins and viral vectors to advanced bio-therapeutics such as mRNA vaccines.